Liquidia will pursue final FDA approval for YUTREPIA™ inhalationLiquidia will immediately request that District Court set aside injunction tied to ‘793 patent MORRISVILLE, N.C., Dec. 20, 2023 .
U S Federal Circuit Affirms Earlier PTAB Decision to Invalidate All Claims of United Therapeutics Patent No 10,716,793 ( 793 Patent) itnewsonline.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from itnewsonline.com Daily Mail and Mail on Sunday newspapers.
Liquidia Corporation (NASDAQ:LQDA) Q3 2023 Earnings Call Transcript November 7, 2023 Liquidia Corporation misses on earnings expectations. Reported EPS is $-0.24 EPS, expectations were $-0.2. Operator: Good morning, and welcome everyone to the Liquidia Corporation Third Quarter 2023 Financial Results and Corporate Update Conference Call. My name is Therese [ph], and I will be your […]
Oral arguments in appeal of ‘793 PTAB decision set for December 4, 2023PDUFA goal date to add PH-ILD indication to YUTREPIA label is January 24, 2024Hired sales force in preparation of potential.